A glimpse of matrix metalloproteinases in diabetic nephropathy

X. Xu, L. Xiao*, P. Xiao, S. Yang, G. Chen, F. Liu, Y. S. Kanwar, L. Sun

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

62 Scopus citations


Matrix metalloproteinases (MMPs) are proteolytic enzymes belonging to the family of zinc-dependent endopeptidases that are capable of degrading almost all the proteinaceous components of the extracellular matrix (ECM). It is known that MMPs play a role in a number of renal diseases, such as, various forms of glomerulonephritis and tubular diseases, including some of the inherited kidney diseases. In this regard, ECM accumulation is considered to be a hallmark morphologic finding of diabetic nephropathy, which not only is related to the excessive synthesis of matrix proteins, but also to their decreased degradation by the MMPs. In recent years, increasing evidence suggest that there is a good correlation between the activity or expression of MMPs and progression of renal disease in patients with diabetic nephropathy and in various experimental animal models. In such a diabetic milieu, the expression of MMPs is modulated by high glucose, advanced glycation end products (AGEs), TGF-β, reactive oxygen species (ROS), transcription factors and some of the microRNAs. In this review, we focused on the structure and functions of MMPs, and their role in the pathogenesis of diabetic nephropathy.

Original languageEnglish (US)
Pages (from-to)3244-3260
Number of pages17
JournalCurrent Medicinal Chemistry
Issue number28
StatePublished - Sep 2014


  • Diabetic nephropathy
  • Extracellular matrix
  • Metalloproteinases
  • TGF-β

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Organic Chemistry


Dive into the research topics of 'A glimpse of matrix metalloproteinases in diabetic nephropathy'. Together they form a unique fingerprint.

Cite this